immediate-release tacrolimus

DRUG3 trials

Sponsors

University of Minnesota, Cedars-Sinai Medical Center, NYU Langone Health

Conditions

Kidney Transplant Failure and RejectionKidney Transplant RejectionLung Transplant

Phase 1

Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients

CompletedNCT03437577

University of MinnesotaKidney Transplant Failure and Rejection

Start: 2018-05-08End: 2020-03-31Updated: 2021-04-15

Phase 2

Envarsus XR in Lung Transplant

CompletedNCT04420195

NYU Langone HealthLung Transplant

Start: 2020-10-23End: 2022-11-30Updated: 2024-01-22

Phase 4

Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

CompletedNCT04225988

Cedars-Sinai Medical CenterKidney Transplant Rejection

Start: 2020-01-09End: 2023-07-11Updated: 2024-07-10

Related Papers

Comparison of Early Conversion to LCP‐Tacrolimus (ENVARSUS XR) to Immediate‐Release Tacrolimus in Lung Transplant Recipients

Clinical Transplantation2025-04-28